Rimonabant is a dual inhibitor of acyl CoA:cholesterol acyltransferases 1 and 2

Molecular characterization of a peripheral receptor for cannabinoids

Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar · Nature · 1993 · 5.1K citations

Medicine, Molecular Biology, Pharmacology +14

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Lisa A. Matsuda, Stephen J. Lolait, Michael Brownstein et al. · Nature · 1990 · 5K citations

Life Sciences, Molecular Biology, Pharmacology +11

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text

Medicine, Neuroscience, Pharmacology +14

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

Luc F. Van Gaal, Aila Rissanen, André Scheen et al. · The Lancet · 2005 · 1.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

Ajay Chawla, William A. Boisvert, Chih‐Hao Lee et al. · Molecular Cell · 2001 · 1.3K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +16